Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$309.38 - $337.38 $12.8 Million - $14 Million
-41,500 Reduced 57.88%
30,200 $9.73 Million
Q2 2024

Aug 14, 2024

SELL
$262.75 - $319.31 $1.05 Million - $1.28 Million
-4,000 Reduced 5.28%
71,700 $22.4 Million
Q1 2024

May 15, 2024

BUY
$268.87 - $324.56 $6.96 Million - $8.41 Million
25,900 Added 52.01%
75,700 $21.5 Million
Q4 2023

Feb 14, 2024

BUY
$255.7 - $288.46 $741,530 - $836,533
2,900 Added 6.18%
49,800 $14.3 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $3.78 Million - $4.7 Million
17,300 Added 58.45%
46,900 $12.6 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $2.06 Million - $2.43 Million
-9,600 Reduced 24.49%
29,600 $6.57 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $4.85 Million - $5.92 Million
21,500 Added 121.47%
39,200 $9.48 Million
Q4 2022

Feb 14, 2023

SELL
$229.03 - $291.01 $1.26 Million - $1.6 Million
-5,500 Reduced 23.71%
17,700 $4.65 Million
Q3 2022

Nov 14, 2022

BUY
$224.46 - $253.15 $5.21 Million - $5.87 Million
23,200 New
23,200 $5.23 Million
Q2 2020

Aug 14, 2020

SELL
$197.81 - $242.74 $1.78 Million - $2.18 Million
-9,000 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$182.24 - $241.7 $5.32 Million - $7.06 Million
-29,200 Reduced 76.44%
9,000 $1.83 Million
Q4 2019

Feb 14, 2020

SELL
$189.21 - $243.2 $10.3 Million - $13.3 Million
-54,700 Reduced 58.88%
38,200 $9.21 Million
Q3 2019

Nov 14, 2019

BUY
$174.11 - $208.62 $14.6 Million - $17.4 Million
83,600 Added 898.92%
92,900 $18 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $783,490 - $918,427
4,700 Added 102.17%
9,300 $1.71 Million
Q1 2019

May 15, 2019

BUY
$180.87 - $203.88 $542,610 - $611,640
3,000 Added 187.5%
4,600 $874,000
Q3 2018

Nov 14, 2018

BUY
$185.29 - $208.89 $296,464 - $334,224
1,600 New
1,600 $332,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.